Patent Assertion Entity

A patent assertion entity (PAE) — also called a non-practicing entity (NPE), or colloquially a 'patent troll' — is a person or company that acquires patents primarily for the purpose of generating revenue through licensing or litigation, rather than to protect its own manufacturing or service products. PAEs typically: (1) acquire patents from inventors, failed startups, bankrupt companies, or as part of patent portfolio transactions; (2) identify companies they believe infringe the acquired patents; (3) send demand letters or file lawsuits asserting the patents; (4) seek licensing fees that are calculated to be less than the cost of litigating (nuisance-value licensing). SCALE: studies estimate PAEs account for 60–70% of patent litigation in the U.S. since the mid-2000s. SPECTRUM: the term covers a broad range from: university technology transfer offices (non-practicing but viewed as legitimate); individual inventors monetizing their own patents (often legitimate); specialized patent licensing companies operating in good faith; to entities whose primary strategy is acquiring broad or questionable patents to extract settlements before targets can mount a defense. NOT ALL NPEs ARE THE SAME: operating companies (OCs) that assert patents related to their technology area are not PAEs in the pejorative sense, even if they license rather than make products in a given market.

PAEs use several legal mechanisms to assert patents and extract licensing fees: (1) DEMAND LETTERS — initial letters claiming infringement and offering a license; often sent before filing suit; must comply with state consumer protection laws (Vermont, Nebraska, Oregon and others have enacted anti-demand-letter statutes requiring specificity); (2) DISTRICT COURT LITIGATION — filing infringement lawsuits in favorable venues; historically, the Eastern District of Texas was favored for its faster trial pace and plaintiff-friendly history; TC Heartland LLC v. Kraft Foods (S.Ct. 2017) significantly restricted venue for corporate defendants to their state of incorporation or where they have regular business activity, reducing Eastern District of Texas filings; (3) INTERNATIONAL TRADE COMMISSION (ITC) — Section 337 proceedings at the ITC can result in exclusion orders barring importation of infringing products; powerful leverage because there is no legal estoppel for NPEs' lack of domestic industry in the technical sense (they can satisfy domestic industry through licensing activity); (4) INTER PARTES REVIEW (IPR) — conversely, defendants initiate IPR petitions at the PTAB to challenge PAE-asserted patents as invalid; IPR has become the primary defense tool since 2012; (5) DECLARATORY JUDGMENT ACTIONS — accused infringers can proactively file for a declaration of non-infringement or invalidity in a more favorable jurisdiction.

Defendants have several strategies for defending against PAE assertions: (1) INTER PARTES REVIEW (IPR) — the most powerful modern tool; a PTAB trial challenging patent validity based on prior art; historically, PAE patents have high invalidity rates (60–70% of IPR petitions result in cancellation of at least some claims); must be filed within 1 year of service of infringement complaint; (2) § 101 INVALIDITY — Alice Corp. v. CLS Bank (S.Ct. 2014) and Mayo Collaborative Services v. Prometheus Labs (S.Ct. 2012) established that abstract ideas, natural phenomena, and natural laws cannot be patented; many PAE-asserted software and business method patents have been invalidated under § 101; (3) CLAIM CONSTRUCTION CHALLENGES — early Markman (claim construction) hearings can narrow or eliminate infringement if the PAE's claims are construed narrowly; (4) NON-INFRINGEMENT — argue that the accused product does not meet every element of the asserted claims; the all-elements rule requires every claim element to be present; (5) LICENSE DEFENSE — if the defendant or its suppliers have a license from any prior holder in the patent's chain of title, patent exhaustion or implied license may apply; (6) LACHES / EQUITABLE ESTOPPEL — if the PAE or its predecessors unreasonably delayed assertion while the defendant invested in the accused technology (though SCA Hygiene Products v. First Quality Baby Products, S.Ct. 2017, limited laches as a defense to infringement damages for future infringement).

Significant judicial and legislative developments have affected the PAE landscape: JUDICIAL: (1) eBay Inc. v. MercExchange (S.Ct. 2006): overturned the presumption that a patent owner winning at trial automatically receives a permanent injunction; PAEs typically cannot show irreparable harm (the traditional requirement for an injunction) because they don't manufacture — after eBay, PAEs generally cannot get injunctions and must accept reasonable royalty damages; (2) Alice Corp. v. CLS Bank (S.Ct. 2014): made it substantially easier to invalidate software patents under § 101, decimating many PAE-asserted patent portfolios; (3) TC Heartland v. Kraft Foods (S.Ct. 2017): restricted venue, reducing filing in plaintiff-friendly venues; (4) Oil States Energy Services v. Greene's Energy Group (S.Ct. 2018): upheld constitutionality of IPR proceedings, preserving the primary invalidity challenge mechanism. LEGISLATIVE: America Invents Act (2011): created IPR and CBM (covered business method review) proceedings at the PTAB — the single most significant structural change affecting PAE activity; fee-shifting provisions in some contexts; state anti-demand-letter statutes. STILL PENDING REFORM: Congress has repeatedly considered but not passed comprehensive patent reform (e.g., PREVAIL Act, PERA) that would further limit PAE litigation, though the landscape continues to evolve.

These terms are often used interchangeably but have distinct meanings: OPERATING COMPANY (OC): a company that manufactures products or provides services and holds patents primarily to protect its business; may assert patents offensively against competitors, but its core business involves practicing technology, not just owning patents; examples: Apple, Qualcomm, IBM. NON-PRACTICING ENTITY (NPE): a broad term for any patent holder that does not practice the patents it asserts; includes: (1) universities and research institutions (legitimate, often mandated by Bayh-Dole to license); (2) individual inventors who license rather than manufacture; (3) technology licensing companies with real licensing businesses; (4) PAEs in the pejorative sense. PATENT ASSERTION ENTITY (PAE): a PAE is a type of NPE characterized by: acquiring patents primarily for assertion rather than research; aggressive, volume-based licensing campaigns; revenue model based on litigation threat rather than actual technology transfer; often using special-purpose entities (SPEs) to hold individual patents, limiting liability and complicating discovery. PATENT TROLL: the pejorative colloquial term for PAEs in the aggressive/abusive category; not a legal term. NUANCE: the categorization matters legally — courts and the ITC treat different types of NPEs differently; domestic industry requirements at the ITC, for example, can be satisfied by a legitimate licensing program even without manufacturing.